Raffa Wealth Management, LLC
- SEC CIK
- 0001631073
- Latest filing
- Jul 27, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Raffa Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 20
- Since Q1 2018
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −33−100.0% | Sold out | Holders |
| Q1 2023 | 33 | $23 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 33 | $75 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 33 | $106 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 33 | $125 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 33 | $178 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 33 | $446 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 33 | $593 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 33 | $566 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 33 | $660 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2020 | 33 | $561 | <0.1% | 00.0% | Unchanged | – |
| Q3 2020 | 33 | $547 | <0.1% | 00.0% | Unchanged | – |
| Q2 2020 | 33 | $764 | <0.1% | 00.0% | Unchanged | – |
| Q1 2020 | 33 | $589 | <0.1% | 00.0% | Unchanged | – |
| Q4 2019 | 33 | $712 | <0.1% | +16+94.1% | Added | – |
| Q3 2019 | 17 | $310 | <0.1% | +17 | New | – |
| Q2 2019 | 0 | $0 | 0.0% | −17−100.0% | Sold out | – |
| Q1 2019 | 17 | $571 | <0.1% | 00.0% | Unchanged | – |
| Q4 2018 | 17 | $559 | <0.1% | 00.0% | Unchanged | – |
| Q3 2018 | 17 | $1.04K | <0.1% | 00.0% | Unchanged | – |
| Q2 2018 | 17 | $830 | <0.1% | 00.0% | Unchanged | – |
| Q1 2018 | 17 | $1.81K | <0.1% | +17 | New | – |